ImmuCell Corporation Property, Plant and Equipment, Gross
ImmuCell Corporation (ICCC) had Property, Plant and Equipment, Gross of $39.91 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-03-30
- 2025-12-31: Property, Plant and Equipment, Gross $39.91M.
- 2025-09-30: Property, Plant and Equipment, Gross $45.94M.
- 2025-06-30: Property, Plant and Equipment, Gross $47.15M.
- 2025-03-31: Property, Plant and Equipment, Gross $46.70M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2025-12-31 | $39.91M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $45.94M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $47.15M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $46.70M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $46.39M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $46.20M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $46.16M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $46.13M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $46.06M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $45.97M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $45.71M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $44.95M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $44.32M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $43.39M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $42.61M 10-Q/A · filed 2022-11-21 | |
| 2022-03-31 | $41.70M 10-Q/A · filed 2022-11-21 | |
| 2021-12-31 | $40.89M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $40.22M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $39.63M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $38.60M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $38.42M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $38.41M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $37.15M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $36.33M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $34.88M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $34.08M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $33.67M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $33.57M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $33.45M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $33.34M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $33.09M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $32.65M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $32.01M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $29.23M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $25.19M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $19.40M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $15.30M 10-K · filed 2018-03-29 | |
| 2016-09-30 | $12.50M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $11.62M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $11.01M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $10.47M 10-K · filed 2017-03-30 | |
| 2015-09-30 | $9.56M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $9.34M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $9.07M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $8.28M 10-K · filed 2016-03-25 | |
| 2014-09-30 | $7.12M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $6.81M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $6.77M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $6.54M 10-K · filed 2015-03-26 | |
| 2013-09-30 | $6.37M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $6.26M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $6.19M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $6.18M 10-K · filed 2014-03-26 | |
| 2012-09-30 | $6.17M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $6.16M 10-Q/A · filed 2012-09-07 | |
| 2011-12-31 | $5.95M 10-K · filed 2013-03-28 | $5.95M 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |